Abstract A quantitative fluorescence-labeled immunosorbent assay and qualitative on-site column tests were developed for the determination of aflatoxin M1 in milk products. The use of liposomes loaded with quantum dots as a label significantly increased the assay sensitivity by encapsulating multiple quantum dots in a single liposome and, therefore, amplifying the analytical signal. Two different techniques were compared to obtain aflatoxin-protein conjugates, used for further coupling with the liposomes. The influence of nonspecific interactions of the liposome-labeled conjugates obtained with the surface of microtiter plates and column cartridges was evaluated and discussed. The limit of detection for fluorescence-labeled immunosorbent assay was 0.014 μg-kg -1 . For qualitative on-site tests, the cutoff was set at 0.05μg-kg -1 , taking into account the EU maximum level for aflatoxin M1 in raw milk, heat-treated milk, and milk for the manufacture of milk-based products. The direct addition of labeled conjugate to the milk samples resulted in an additional decrease of analysis time. An intralaboratory validation was performed with sterilized milk and cream samples artificially spiked with aflatoxin M1 at concentrations less than, equal to and greater than the cutoff level. It is shown that milk products can be analyzed without any sample preparation, just diluted with the buffer. The rates for false-positive and false-negative results were below 5 % (2.6 % and 3.3 %, respectively).
Introduction
Concern about food safety requires the development of rapid and sensitive on-site tests suitable for nonlaboratory application. This is especially important for perishable goods, as their short lifetime demands no-delay screening.
One of the contaminants possibly present in food in very low concentrations is aflatoxin M1 (AfM1). Aflatoxins are highly toxic secondary metabolites of Aspergillus species. AfM1, the major metabolite of aflatoxin B1 (AfB1), generated by its hydroxylation in mammals and subsequently secreted in milk of lactating cows, is one of the most dangerous pollutants of milk and milk products. Both AfB1 and AfM1 are characterized by carcinogenic and hepatotoxic activity, so AfM1 has been classified by the International Agency for Research on Cancer among other naturally occurring aflatoxins as possibly carcinogenic to humans (group 2B carcinogen) [1] . AfM1 is relatively stable during milk storage and thermal processing, as well as during production of various dairy products [2] . This makes AfM1 very dangerous for human health. The maximum limit (ML) of AfM1 in milk established by the US Food and Drug Administration is 0.5 ng mL -1 [3] . This value for AfM1 in raw milk, heattreated milk, and milk for the manufacture of milk based products according to European Commission Regulation No 1881/2006/EC was set at 0.05 μg kg -1 [4] .
There are a lot of published data concerning the contamination of milk and milk products with AfM1. For example Alborzi et al. [5] described 100 % contamination of analyzed Iranian milk samples with AfM1, and Rastogi et al. [6] found this mycotoxin in 87.3 % of tested Indian milk products. Unusan [7] mentioned that the level of AfM1 was above the EU ML in 47 % of analyzed milk samples. Very recently, AfB1-contaminated feed was available on the EU market and was fed to lactating cows [8] . Therefore, the problem of the occurrence of AfM1 in milk deserves a lot of scientific attention and requires the development of both laboratory and onsite methods.
High-performance liquid chromatography with fluorimetric detection coupled with cleanup by immunoaffinity columns is the reference method used for the determination of aflatoxins in milk [9] . But a great variety of rapid techniques for AfM1 detection in milk have been published [10] . Most of them are immunochemical tests based on highly specific antigen-antibody interactions. All published immunochemical techniques can be divided into instrumental methods and noninstrumental tests. Enzyme-linked immunosorbent assay [9, 11, 12] , ultrasensitive chemiluminescent enzyme immunoassay [13] , flow-injection immunoassay with amperometric detection [14] , and different kinds of sensors [15, 16] have been described. Enzyme-linked immunosorbent assay was even included in ISO guidelines [17] and was used for legal purposes (but it requires confirmation by a reference technique). These techniques are characterized by good analytical performances, but they are not suitable for on-site application.
One of the most popular on-site formats applied for AfM1 determination is lateral-flow immunoassay (LFIA). LFIA allows the determination of AfM1 with a visual limit of detection (LOD) of 0.3 ng mL -1 [18] and 1 ng mL -1 [11] . Several commercially available LFIAs for AfM1 determination in milk are appropriate for qualitative and semiquantitative detection. However, LFIA often cannot reach the expected sensitivity, according to the established EU ML (the LOD of the RBiopharm commercial test is 4 μg kg -1 , the LOD of the test produced by Charm Science is 0.5 μg kg -1 , and LOD of the test developed by Creative Diagnostics is 0.3 μg kg -1 ). To achieve this value some preliminary sample pretreatment is required [the tests from Romer Labs (LOD of 0.047 μg kg ]. This can be explained by the impossibility of LFIA to concentrate the target analyte.
A gel-based column immunoassay allows the combination of purification, concentration, and sensitive enzymebased detection in one setup. Goryacheva et al. [19] achieved a cutoff level for AfM1 of 0.04 μg kg -1 because 10 mL of milk could be passed through the immunochemical column. The large volume allowed the analyte to be preconcentrated and a high sensitivity to be obtained, but on the other hand, it gave rise to high matrix interference and needed a centrifugation step for milk defatting.
The most popular labels for immunoassays are enzymes. They provide high sensitivity, but also could be one of the main reasons for false results owing to the susceptibility of enzymes to matrix constituents. Besides, additional analysis steps such as washing and application of a chromogenic substrate are necessary. Moreover, the enzymatic reaction is time-dependent, and strict compliance with the assay protocol described is important.
Different kinds of particulate and nanosized labels have been used for immunoassays, e.g., colloidal gold, colloidal carbon, "colloidal dyes," colloidal selenium, magnetic nanoparticles, lanthanides, dye-entrapped polystyrene, liposomes, and latex [20] [21] [22] . Each of these has its own strengths and weaknesses.
Quantum dots (QD) now play a significant role in biotechnological and bioanalytical research owing to their unique spectral properties such as intense fluorescence, high photostability, tunable emission spectra, high-quantum yield, and low photobleaching [23] . But transfer of water-insoluble QDs into aqueous media usually results in a decrease of the luminescence yield [24] . However, they can be transferred into aqueous media after being loading into liposomes, with retention of their spectral characteristics [25] .
Liposomes are spherical lipid vesicles. The lipid molecules consist of hydrophilic and hydrophobic groups, so in aqueous solutions they semiorganize to increase the solubility. Because of their extensive internal volume, liposomes can carry not one marker, but a high number of markers; therefore, liposomes were applied in immunoassay [26] [27] [28] .
The goal of this investigation was the development of a novel ultrasensitive immunochemical on-site test for AfM1 determination in milk based on luminescent determination of the analytical signal. QD-loaded liposomes (LQD) were synthesized and used as a label.
Experimental

Reagents and materials
Lipoid S75 was purchased from Lipoid (Ludwigshafen, Germany). N-Hydroxysuccinimide, 3-(2-pyridyldithio)propionic acid N-hydroxysuccinimide ester (SPDP), ethyl-3-(3-dimethylamino propyl)carbodiimide, dithiothreitol (DTT), O-(carboxymethyl) hydroxylamine hemihydrochloride (CMO), ovalbumin (OVA) from chicken egg white, bovine serum albumin (BSA), N,Ndimethylformamide (DMF), Sephadex G-75, 2-(N-morpholino) ethanesulfonic acid (MES), and EDTA tetrapotassium salt were purchased from Sigma-Aldrich (Bornem, Belgium). AfM1 was supplied by Fermentek (Jerusalem, Israel). Imject cationized BSA (cBSA) and protein concentrators (9 K, 20 mL) were purchased from Thermo Scientific (Rockford, USA). AntiAfB1 (monoclonal) was obtained from Soft Flow Hungary (Pecs, Hungary). It was characterized by 79 % cross-reaction with AfM1, 33 % cross-reaction with aflatoxin M2, 76 % cross-reaction with aflatoxin B2, 55 % cross-reaction with aflatoxin G1, 6 % cross-reaction with aflatoxin G2, and no crossreaction with aflatoxin B2a and aflatoxin G2a [29] . CNBractivated Sepharose 4B was purchased from GE Healthcare Bio-Sciences (Uppsala, Sweden). Plastic tubes (Bond Elut cartridges, 1 mL) and polyethylene frits (0.25-in. diameter) were supplied by Varian Belgium (Sint-Katelijne-Waver, Belgium). Microtiter plates (96 flat-bottom wells with high binding capacity; black MaxiSorp) were purchased from Nunc (Roskilde, Denmark). Certified reference material-whole milk powder with an AfM1 certified value of 111±0.018 μg-kg -1 and 0.44±0.06 μg kg -1
-was supplied by the Institute for Reference Materials and Measurements (European Commission, Joint Research Centre, Geel, Belgium). Milk products (milk, cream) were bought in Belgian supermarkets.
The size distribution of the liposomes was measured by using a Zetasizer Nano ZS (Malvern Instruments, Malvern, UK). All measurements were conducted at 25°C.
Water-insoluble CdSe/3CdS/2ZnS core/shell/shell QDs were synthesized by Elena S. Speranskaya and Valentina V. Goftman (Saratov State University, Saratov, Russia).
Synthesis of AfB1-cBSA and AfM1-cBSA For aflatoxin-cBSA synthesis, a technique adapted from that described by Zhou et al. [30] was applied. The mycotoxin (approximately 1 μmol) was dissolved in 1 mL of 0.1 M MES buffer (pH 4.8, containing 100 μL of DMF) and added dropwise to cBSA solution (0.025 μmol). Formaldehyde (150 μL) was added. The mixture was gently stirred for 24 h at 37°C. For removal of unbound low molecular weight substances, protein concentrator tubes (9 K, 20 mL) were used. The concentrations of the conjugates obtained were determined spectrophotometrically. AfB1-cBSA (0.7 mg mL -1 ) and AfM1-cBSA (0.6 mgmL -1 ) were kept at −18°C.
Synthesis of AfB1-OVA and AfM1-OVA CMO was used to include carboxyl groups in AfB1 and AfM1. The AfB1-OVA and AfM1-OVA conjugates were synthesized according to the standard technique of Nhydroxysuccinimide/N,N′-dicyclohexylcarbodiimide activation of the hapten's COOH group. N-Hydroxysuccinimide (approximately 2 μmol) and ethyl-3-(3-dimethylaminopro pyl)carbodiimide (approximately 2 μmol) in DMF were added dropwise to the derivatized mycotoxin solution obtained (approximately 0.2 μmol), and the reaction mixture was kept for 2.5 h at room temperature under constant magnetic stirring. The activated derivate was mixed with the previously cooled OVA solution (approximately 4 nmol) and the mixture was kept for 2 h at room temperature under stirring, followed by overnight incubation at 4°C.
The conjugates were dialyzed for 3 days against phosphate-buffered saline (PBS) at 4°C with constant stirring. The concentrations of AfB1-OVA (0.3 mg mL -1 ) and AfM1-OVA (0.3 mg mL -1 ) were determined spectrophotometrically. The conjugates obtained were kept at −18°C.
Preparation of LQD
The preparation of LQD was based on the technique described by Bangham et al. [31] . Lipoid S75 (94 μmol) and the water insoluble QDs (1 nmol) were dissolved in 1 mL of chloroform. The organic solvent was removed by rotary evaporation at 45°C. Then, 6 mL of PBS was added to the dried lipids and the mixture was vigorously stirred in a water bath at 45°C for 30 min. The desired particle size was obtained by sonication (5 min). The liposome suspension was centrifuged at 20,000 g for 15 min at room temperature and the supernatant was removed. The pellet was redissolved in PBS and used for further experiments. The LQD solution obtained was stored at 4°C and was stable for at least 1 month.
Synthesis of liposome-labeled conjugate SPDP (1.8 mg in 300 μL of ethanol) was added dropwise to the analyte-protein conjugates (AfM1-OVA, AfB1-OVA, AfB1-cBSA, AfM1-cBSA; 2 μmol of conjugate in 2 mL of 0.1 M sodium phosphate buffer, pH~7.5). The reaction mixtures were stirred for 30 min at room temperature, and excess of the cross-linker was removed by application of the protein concentrator tubes (9 K, 20 mL). The residues were reconstituted in sodium acetate buffer (pH~4.5). To release pyridine-2-thione, DTT (0.8 mg in 100 μL of acetate buffer) was added dropwise to the SPDP-modified protein conjugates, and the reaction continued for 30 min under constant stirring at room temperature. Excess DTT was removed by the protein concentrator tubes (9 K, 20 m), and the modified conjugates were reconstituted in 0.05 M sodium phosphate buffer (containing 1 mM EDTA).
For thiolation of liposomes, 300 μL of SPDP (2.5 μmol) was mixed with 2 mL of LQD. The reaction mixture was stirred for 2 h at room temperature, and excess cross-linker was removed by a protein concentrator tube. The vesicles were suspended in 0.05 M sodium phosphate buffer containing 1 mM EDTA.
The solution of modified LQD (1.7 mL) was added dropwise to the thiolated analyte-protein conjugates. Reactions were performed under constant stirring overnight at room temperature. The modified liposomes were separated from excess protein by gel filtration using Sephadex G-75 and kept at 4°C. The conjugates prepared were stored at 4 •C and were stable for at least 1 month.
Microtiter plate fluorescence-labeled immunosorbent assay
The 96-well opaque black microtiter plates were coated with anti-AfB1 antibody (dilution 1:50,000, 100 μL per well) in coating buffer (0.05 M sodium carbonate buffer, pH~9.6) by overnight incubation at 4°C or for 2 h at 37°C. Afterwards, the plates were washed three times with PBS containing 0.05 % (v/v) Tween 20 (PBST) and blocked for 1 h at 37°C with PBS containing 2 % casein (w/v). The plates were later washed two times with PBST. AfM1 standard solution in PBS or diluted milk sample (50 μL per well) was added simultaneously with the LQD-labeled conjugate (dilution 1:50, 50 μL per well). After 1 h incubation, the plates were washed four times with PBST. The content of each well was redissolved in 100 μL of PBS. Luminescence was measured using an EnVision 2104 multilabel plate reader (PerkinElmer, Waltham, USA).
The standard fluorescence-labeled immunosorbent assay (FLISA) sigmoidal curve was plotted on a semilogarithmic scale: luminescence intensity or relative luminescence intensity (ratio of values of luminescence intensity measured at standard concentrations and zero concentration) against the logarithm of the analyte concentration. It is described by the Rodbard function:
where А is the maximum luminescence intensity, D is the minimum luminescence intensity, b is the slope of the curve in the plot of the half maximal inhibitory concentration (IC 50 ), and С is the IС 50 of the analyte. The LOD was defined as three times the signal-to-noise ratio.
Gel-based immunoassay for on-site detection Sepharose 4B gel coupled with the anti-AfB1 antibody (9 μL of antibody for 0.5 g of Sepharose 4B; coupled gel) and gel with blocked active groups (blocked gel) were prepared according to the standard procedure [32] . The mixture of coupled and blocked gels (200 μL) was placed between two polyethylene frits inside an empty 1-mL Bond Elut column. The column was kept at 4°C until use. Before analysis, the immunochemical columns were additionally blocked with 1 % glycine (w/v) in 0.1 M hydrocarbonate buffer (pH~8). AfM1 standard solution (1 mL) or diluted milk sample (1 mL) was passed through the column. After a washing step with 1 mL of PBS, 100 μL of labeled conjugate (diluted 1:50) was added and the mixture was incubated for 6 min. Afterwards, excess conjugate was removed with 1 mL of PBS. Visual detection was performed immediately after the washing step under a UV lamp (365 nm).
Polyethylene frit-based immunoassay for on-site detection
The frit-based column immunoassay procedure was described in our previous publications [32, 33] . First, polyethylene frits were degassed in ethanol by ultrasonication (15 min). Then, they were placed in 1-mL Bond Elut cartridges, and 300 μL of ethanol/water (50;50, v/v), 300 μL of water, and 600 μL of carbonate buffer were passed through the columns for further activation. The anti-AfB1 antibody (200 μL, diluted 1:30,000 in sodium carbonate buffer) was immobilized directly onto the activated polyethylene frits and incubated for 20 min at 37°C. Excess unbound antibody was removed, and the surface of the frits was blocked with PBS containing 3 % casein (500 μL per frit, 15 min incubation, 37°C). The further procedure was similar to that described for the gel-based immunoassay (GBI).
In another variant of this on-site test, the labeled conjugate was directly added to the milk sample prior to its analysis. This approach allowed us to shorten the analysis procedure. In this case, visual detection was realized immediately after the sample addition and washing step. PBS (2 mL) was used to remove excess unbound conjugate.
Analytical performance of the column tests
The cutoff level of the column tests was defined as the lowest AfM1 concentration which did not result in the appearance of luminescence. The absence of luminescence of the test layer was considered as a positive result (analyte concentration at or above the cutoff level), and the presence of luminescence, independent of its brightness, was considered as a negative result (analyte concentration below the cutoff level). Samples with AfM1 concentrations higher (or lower) than the cutoff level which resulted in negative results (or positive results) were considered to be false negative (or false positive).
Sample preparation
For the preparation of milk and cream samples, a fivefold dilution with PBS was used. Milk powder was suspended in distilled water and dissolved by stirring. For each milk sample, control portions were prepared at an AfM1 concentration of 0.05 μg kg -1 .
Result and discussion
Preparation of LQD-labeled conjugates for AfM1 determination LQD were prepared by thin-film evaporation using soybean lecithin derived material (Lipoid S75). This procedure consists of two steps: the formation of a thin film of phospholipids and its hydration for the formation of liposomes. In this work CdSe/3CdS/2ZnS core/shell/shell QDs were used. Uncovered CdSe nanocrystals are characterized by low quantum yield and they are not photostable [34, 35] . The quantum yield and photostability can be sufficiently improved by growing an inorganic shell of a wider band-gap semiconductor around the CdSe cores [34] . In this work, the successive ionic layer adsorption and reaction technique was used to cover the CdSe cores with an inorganic ZnS shell. The initial CdSe core (emission wavelength 524 nm) has a quantum yield of 1.5 %, whereas after the coating with CdS and ZnS layers, the quantum yield of the QDs was sufficiently increased (approximately 35 %).
As the molecular structures of AfB1 and AfM1 are similar and the difference is just one hydroxyl group, it is more than possible that antibodies against AfM1 could be characterized with high cross-reactivity to AfB1, and vice versa, antibodies against AfB1 could be sensitive to AfM1 too. Therefore, both AfB1 and AfM1 were used to synthesize labeled conjugates for AfM1 determination. Neither AfB1 nor AfM1 contains active groups suitable for binding with proteins. Therefore, two different conjugation techniques were used to couple aflatoxin molecules with proteins. The first method was based on the synthesis of carboxymethoxylamine derivates of AfM1 and AfB1. The other approach was based on the Mannich reaction of the mycotoxin with cBSA and consisted of imidization of N-hydroxymethyl amine groups of cBSA, enolation of aflatoxin, and reaction when electrophilic iminium ionized BSA attacked the carbon nucleophilic center of the enolated aflatoxin. Addition of formaldehyde to the reaction mixture was necessary because it participates in cBSA imidization. The reaction was conducted in MES buffer (pH~4.8) since acidic conditions are important for ketone enolization. The analyte-protein conjugates prepared were used for coupling with LQD. Lipoid S75 contains 7-10 % (w/w) phosphatidylethanolamine, which provides active amino groups on the surface of liposomes and stabilizes the vesicles obtained. Both the analyte-protein conjugates and the LQD were modified by SPDP, the heterobifunctional cross-linker. Amino groups of LQD reacted with SPDP and formed an amide bond. The 2-pyridyldithiol end of SPDP participated in the formation of a disulfide linkage with sulfhydryl groups of other molecules. Therefore, after activation of the proteins and LQD with SPDP, they reacted and coupled with each other.
FLISA for AfM1 determination
Four conjugates (AfB1-cBSA-LQD, AfM1-cBSA-LQD, AfB1-OVA-LQD, AfM1-OVA-LQD) were applied for AfM1 determination by FLISA. It was the objective to develop FLISA with a sensitivity close to or lower than the ML for AfM1 in milk and milk products established by the European Commission. The envisaged sensitivity was reached through variation of antibody and labeled conjugate concentrations. The conjugates obtained via CMO derivatives were characterized by a considerably stronger nonspecific interaction with the microtiter plate than the conjugates based on the binding with cBSA. To level this interaction, a high casein concentration was used in the blocking solution (PBS-2 % casein, w/v). This resulted in the suppression of luminescence intensity, and for amplification of the analytical signal the antibody concentration was increased. Thus, the sensitivities of AfM1 determination with AfB1-OVA-LQD (IC 50 of 0.32-μg kg ) allowed us to analyze AfM1 in milk products. As the LOD was considerably lower than the EU ML for AfM1 in milk, it allowed us to use high dilution of milk samples.
Column tests for AfM1 determination
As carriers for antibody immobilization, CNBr-activated Sepharose gel and thin polyethylene frits were used. The ). Because of sample dilution (1:5 with PBS), the assay sensitivity should be around 0.01 μg kg -1 . The analytical signal was registered by the naked eye, so the luminescence intensity should be high enough for unambiguous detection. At the same time, the assay sensitivity should be high enough to reach the established ML. In the frit-based immunoassay (FBI) the specific antibody was directly coated onto the frit surface; eight different antibody concentrations were compared (dilutions were from 1:500 to 1:30,000 in sodium carbonate buffer). In the GBI, when the antibody was covalently bound with active CNBr groups of Sepharose, various dilutions of coupled gel with blocked gel were checked (from 1:10 to 1:75). Low antibody concentrations in the FBI (dilution higher than 1:30000) or high gel dilutions in the GBI (higher than 1:50) showed a very low intensity of the analytical signal, which could cause false results during the analysis of real samples. As optimal conditions, an antibody dilution of 1:30000 for FBI and 1:50 gel dilution for GBI were chosen. The optimal AfB1-cBSA-LQD dilution was 1:50.
The optimal time for antibody coating in FBI was 20 min at 37°C. Further incubation did not lead to an increased analytical signal, but a shorter coating time was not enough. Blocking in FBI was necessary to prevent undesirable physical absorption of the labeled conjugate on the frit's surface. Thus, blocking was done with 3 % casein-PBS (w/v) for 15 min at 37°C.
PBS-Tween 20 (0.1 % v/v) was used as washing buffer for conjugate dilution in both FBI and GBI. For additional blocking of the gel in GBI, 1 % glycine (w/v) in 0.1 M NaHCO 3 buffer (pH~8) was added to the already prepared immunocolumns, incubated for 10 min at room temperature, and passed through. This was done to block unbound CNBr groups of Sepharose.
To decrease the analysis time and simplify the analytical procedure, the labeled conjugate was also directly added to the analyzed samples. This approach enabled us to completely level the nonspecific interaction of AfB1-cBSA-LQD with the polyethylene frit without using additional blocking with casein. This was possible because milk as a multicomponent mixture, which contains different proteins, acted as an additional blocking agent. But, the presence of this protein mixture decreased the luminescence of the LQD-labeled conjugate, so the concentration of AfB1-cBSA-LQD had to be increased (in this case the optimal dilution of AfB1-cBSA-LQD was 1:40). For washing, 5 mL of PBS was used to remove excess unbound conjugate.
The cutoff value achieved was 0.05 μg kg -1 in both formats, with a visible and clear contrast in luminescence between positive and negative samples (Fig. 2) .
Validation of the techniques developed FLISA validation was performed with milk and cream samples artificially spiked with AfM1 at concentrations less than, equal to, and greater than the established ML for AfM1 in milk products. As a sample pretreatment, a fivefold dilution of milk with PBS was used. LQD are less susceptible than enzymes to the matrix content, and luminescence is easier to detect by the naked eye. The correlation between added amounts of AfM1 and found concentrations is pointed out in Fig. 3 . The graphs obtained demonstrate good applicability of the technique developed for the screening of milk samples. For accuracy control, two certified reference materials with AfM1 concentrations of 0.111±0.018 μg kg -1 and 0.44±0.06-μg kg -1 were used, and 0.093 μg kg -1 and 0.452 μg kg -1 , respectively, were found by FLISA.
The validation of on-site column tests was performed with a sterilized milk sample artificially spiked with AfM1. Standard solutions and artificially spiked milk samples with AfM1 concentrations equal to or greater than the cutoff level resulted in the observation of no luminescence under a UV lamp. Inversely, standard solutions and artificially spiked milk samples with AfM1 concentrations less than 0.05 μg kg -1 resulted in bright luminescence under UV light (Fig. 4) .
Performance parameters were calculated on the basis of the summarized data of repeated experiments. The rates for falsepositive and false-negative results were below 5 % (2.6 % and 3.3 %, respectively), and the specificity and sensitivity rates were greater than 95 %, and so were according to Commission Decision 2002/657/EC [36] .
Conclusion
LQD were used to detect an analytical signal in two different formats of immunosorbent assay: FLISA and noninstrumental qualitative column tests (gel-based and frit-based formats). Two different approaches for AfM1-protein conjugate preparation were evaluated, and use of cBSA was found to be optimal. Direct addition of labeled conjugate to the analyzed samples was successfully applied, and thereby the analysis procedure could be shortened and simplified. The cutoff values were aimed at the ML for AfM1 in milk products established by the European Commission (0.05 μg kg -1 ). Application of the LQD allowed us to achieve an IC 50 value in FLISA of 0.014 μg kg -1 , and the cutoff for both on-site formats of 0.05 μg kg -1 . The ultrasensitive systems developed for AfM1 determination were tested and validated for rapid screening of milk products.
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